| Previous Close | 45.90 |
| Open | 46.22 |
| Bid | 46.33 x 1400 |
| Ask | 46.41 x 1000 |
| Day's Range | 46.07 - 46.76 |
| 52 Week Range | 28.74 - 55.03 |
| Volume | 68,997 |
| Avg. Volume | 93,108 |
| Net Assets | 287.46M |
| NAV | 45.86 |
| PE Ratio (TTM) | N/A |
| Yield | 0.26% |
| YTD Daily Total Return | -2.28% |
| Beta (5Y Monthly) | 0.00 |
| Expense Ratio (net) | 0.47% |
| Inception Date | 2019-06-11 |
- Investopedia
Best Biotech ETFs for Q2 2021
Biotech companies use or modify biological processes in order to create new pharmaceuticals or therapies. The biotech sector is particularly closely followed right now as a number of biotech companies around the world rush to develop potential vaccines for COVID-19.
- Yahoo Finance Video
Biotech ETFs to watch as companies push for coronavirus treatments
Yahoo Finance's Seana Smith and ETF Trends CIO and Director Dave Nadig discuss the outlook on biotech ETFs as optimism grows over results for coronavirus treatments.
© 2021 Verizon Media. All rights reserved.
